The ghosts of departed quantities: approaches to dealing with observations below the limit of quantitation
Abstract
A common but not necessarily logical requirement in drug development is that a 'limit of quantitation' be set for chemical assays and that observations that fall below the limit should not be treated as real data but should be labelled as below the limit and set aside for special treatment. We examine five of seven approaches to analysing such data considered by Beal in 2001, concentrating in particular on two: one that treats the data as a truncated sample and another that treats them as a censored sample. In fact, using a pattern-mixture framework, one can show that the former consists of using the conditional distribution of the 'acceptable values' and the latter adds the information from the marginal mixing distribution. We illustrate these approaches with a real example, concentrating in particular on the two likelihood-based methods, provide various formulae that may be used to compare these and other approaches, check these formulae using simulations and make some recommendations as to which approach one should use.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Concentration data below LOQ but not below LOD were included to evaluate the excretion profile because inclusion can result in a better fit and excluding or replacing them with zero could lead to biased pharmacokinetic parameters.
“Concentration data below the LOQ (but not below the LOD) were included to evaluate the excretion profile, as their inclusion can result in a better fit of the excretion profile model, while excluding or replacing them with zero could lead to biased pharmacokinetic parameters [39,40,41,42].”
From Urinary Elimination of Ecdysterone and its Metabolites following a Single-Dose Administration in Humans (2021) · cites this paper as [42]
Cited by
Sorted by citations
Ambrosio, G., Yuliandra, T., Wuest, B., Mazzarino, M., Torre, X. D. L., Botrè, F., Diel, P., Isenmann, E., & Parr, M. K. (2021) · doi:10.20944/preprints202105.0106.v1 · Cited by 16 · see citing works
“…following the administration of 50 14-deoxy-poststerone of ecdysterone and 14-deoxy-ecdysterone 14-deoxy-ecdysterone in post-administration urine samples and consequently their excretion Concentration data below below the LOQ (but not below the LOD) were included to evaluate parameters [39–42].”
BackgroundMethod
- Authors
- Senn, S., Holford, N., & Hockey, H.
- Affiliations
- Centre de Recherche Public de la Santé (LU)
- Department of Pharmacology and Clinical Pharmacology University of Auckland Auckland New Zealand
- Biometrics Matters Limited 13 Nevada Road Hamilton 3126 New Zealand
- Corresponding author
- Senn, Stephen
- ORCID
- Senn, Stephen
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 2012-07-24
- Volume
- 31
- Issue
- 30
- Pages
- 4280-4295
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- OpenAlex
- W2126541486
- Cited by
- 38
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2023: 6 · 2022: 2 · 2021: 8 · 2020: 2 · 2018: 5 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 3
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Statistics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- University of Glasgow
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Keywords
- limit of quantification, truncated data, censored data, pattern-mixture models, likelihood methods, drug development
- MeSH terms
- Antifungal Agents, Data Interpretation, Statistical, Humans, Models, Theoretical, Pharmacokinetics, Pyrimidines, Research Design, Triazoles, Reproducibility of Results, Bias, Normal Distribution, Likelihood Functions, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review